Latest filing published 12 Jan 2023 for Idera Pharmaceuticals, INC., €14k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Michael R. Dougherty is a declared insider at 2 companies (board member); the most frequent names are Idera Pharmaceuticals, Inc. and Marinus Pharmaceuticals, Inc. The record holds 8 filings, for trades running from 1 June 2021 to 11 January 2023.
The open-market record is one-sided, with 1 purchase worth €83k and not one sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Outside the open market, there are 7 share grants.
Most recently, on 12 January 2023, the filings show a share grant worth €14k in Idera Pharmaceuticals, Inc. The last purchase on record was published on 3 June 2021, which is 1,963 days ago. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 of 8 declarations